| Prev Close: | 5.60 |
|---|---|
| Open: | 5.67 |
| Bid: | 5.88 x 1100 |
| Ask: | 5.91 x 400 |
| 1y Target Est: | 6.00 |
| Beta: | 1.75 |
| Next Earnings Date: | 5-Aug-13 |
| Day's Range: | 5.59 - 5.92 |
|---|---|
| 52wk Range: | 2.62 - 5.92 |
| Volume: | 373,347 |
| Avg Vol (3m): | 217,615 |
| Market Cap: | 367.56M |
| P/E (ttm): | N/A |
| EPS (ttm): | -0.46 |
| Div & Yield: | N/A (N/A) |
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- PSivida Corporation And GTx: 2 Of The Most Undervalued Biotechs For 2013at Seeking Alpha(Mon, May 20)
- The Best- And Worst-Performing Biotech Stocks, May 3 To May 10at Forbes(Sat, May 11)
- GTX INC /DE/ FinancialsEDGAR Online Financials(Fri, May 10)
- Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buyat Seeking Alpha(Tue, May 7)
- GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of SecuriEDGAR Online(Mon, May 6)
- GTX INC /DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 6)
- GTx Inc.'s CEO Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Fri, May 3)
- GTx, Inc. Earnings Call scheduled for 9:00 am ET todayCCBN(Fri, May 3)
- Q1 2013 GTx, Inc. Earnings Release - Before Market OpenCCBN(Fri, May 3)
- GTx Provides Corporate Update and Reports First Quarter 2013 Financial ResultsBusiness Wire(Fri, May 3)
- GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online(Fri, May 3)
- Biotech Stock Value Fundamentally Based on Individual Drug Development and the Competing Landscape: Expert Analyst Boris Peaker Discusses His Coverage of the Biotechnology Sector with The Wall Street TranscriptWall Street Transcript(Wed, May 1)
- GTx Initiating Phase 2, Open-Label Study of Enobosarm to Treat ER Positive Metastatic Breast CancerBusiness Wire(Tue, Apr 30)
- GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Tue, Apr 30)
- GTx, Inc.: Is This Microcap Breaking Out?at Seeking Alpha(Thu, Apr 25)
Press Releases
- GTx Provides Corporate Update and Reports First Quarter 2013 Financial ResultsBusiness Wire(Fri, May 3)
- GTx Initiating Phase 2, Open-Label Study of Enobosarm to Treat ER Positive Metastatic Breast CancerBusiness Wire(Tue, Apr 30)
- GTx, Inc. To Host First Quarter 2013 Financial Results Conference Call and WebcastBusiness Wire(Fri, Apr 19)
Reports
- ValuEngine Industry Report for Medical-biomed/geneticsValuEngine, Inc.(May 21)
- GTX INC (GTXI) - REPORT FOR ACTIVE TRADERSPechala's Reports(May 20)
- GTX INC (GTXI) 12-months forecastPechala's Reports(May 18)